Geoff Mulgan reimagines the state as a lean, agile force that delivers power without the drag of bureaucracy.

Since 2007, Jezebel has been the Internet's most treasured source for everything celebrities, sex, and politics...with teeth.

Studying how pizza structure responds to vehicle weight shows how toppings and crust deform. Trump quips about seeking DOJ settlement: 'I hereby give myself $1 billion' Braves outfielder who made ...

TICKETS. Get the best tickets for Boxing events and more at Tickets MARCA Doubts surround Anthony Joshua's confidence as Fury and Tate challenge Jake Paul fight narrative UFC legend gives bold ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Shares of Structure Therapeutics surged Monday after the biotechnology company said an experimental pill helped people lose substantial weight in a mid-stage clinical trial. The shares more than ...

We recently published 10 Stocks Standing Tall Amid Market Fall; 6 Hit Record Highs. Structure Therapeutics Inc. (NASDAQ:GPCR) is one of the best performers on Monday. Structure Therapeutics soared to ...

Structure’s aleniglipron elicited over 11% weight loss in a Phase II trial, sending the biotech’s stock up nearly 103% as markets closed on Monday. Structure Therapeutics’ investigational oral GLP-1 ...

Dec 8 (Reuters) - Structure Therapeutics (GPCR.O), opens new tab said on Monday its obesity pill showed weight loss of up to 11.3% after 36 weeks of treatment in a mid-stage study, driving the company ...

A pill from Structure Therapeutics Inc. helped patients lose roughly as much weight as a rival treatment from Eli Lilly & Co., giving the startup an edge as it seeks to break into the highly ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...